Singular Genomics Systems Inc (OMIC)
0.38
-0.02
(-5.14%)
USD |
NASDAQ |
Apr 26, 14:12
Singular Genomics Systems Cash from Financing (TTM): 0.696M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.696M |
| September 30, 2023 | 1.374M |
| June 30, 2023 | 1.401M |
| March 31, 2023 | 0.884M |
| December 31, 2022 | 0.901M |
| September 30, 2022 | 0.961M |
| June 30, 2022 | -0.386M |
| Date | Value |
|---|---|
| March 31, 2022 | 238.67M |
| December 31, 2021 | 372.13M |
| September 30, 2021 | 371.35M |
| June 30, 2021 | 372.64M |
| March 31, 2021 | 133.49M |
| December 31, 2020 | 7.515M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.386M
Minimum
Jun 2022
372.64M
Maximum
Jun 2021
115.51M
Average
1.401M
Median
Jun 2023
Cash from Financing (TTM) Benchmarks
| Bruker Corp | -193.40M |
| Azenta Inc | -452.51M |
| Harvard Bioscience Inc | -12.13M |
| Bionano Genomics Inc | 113.82M |
| Akoya Biosciences Inc | 56.84M |